398 related articles for article (PubMed ID: 31032905)
1. Regulation of regulatory T cells in cancer.
Stockis J; Roychoudhuri R; Halim TYF
Immunology; 2019 Jul; 157(3):219-231. PubMed ID: 31032905
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
Yano H; Andrews LP; Workman CJ; Vignali DAA
Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
[TBL] [Abstract][Full Text] [Related]
3. Unlocking the Complexities of Tumor-Associated Regulatory T Cells.
Chao JL; Savage PA
J Immunol; 2018 Jan; 200(2):415-421. PubMed ID: 29311383
[TBL] [Abstract][Full Text] [Related]
4. Treg programming and therapeutic reprogramming in cancer.
Moreno Ayala MA; Li Z; DuPage M
Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle.
Hatzioannou A; Boumpas A; Papadopoulou M; Papafragkos I; Varveri A; Alissafi T; Verginis P
Front Immunol; 2021; 12():731947. PubMed ID: 34539668
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells in cancer: where are we now?
Gallimore A; Quezada SA; Roychoudhuri R
Immunology; 2019 Jul; 157(3):187-189. PubMed ID: 31225653
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide 3-kinaseĀ Ī“ is a regulatory T-cell target in cancer immunotherapy.
Lim EL; Okkenhaug K
Immunology; 2019 Jul; 157(3):210-218. PubMed ID: 31107985
[TBL] [Abstract][Full Text] [Related]
9. Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
Colbeck EJ; Hindley JP; Smart K; Jones E; Bloom A; Bridgeman H; McPherson RC; Turner DG; Ladell K; Price DA; O'Connor RA; Anderton SM; Godkin AJ; Gallimore AM
Oncotarget; 2015 Sep; 6(28):24649-59. PubMed ID: 26433463
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
[TBL] [Abstract][Full Text] [Related]
11. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
Luo CT; Liao W; Dadi S; Toure A; Li MO
Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
13. Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
Yoshida K; Okamoto M; Sasaki J; Kuroda C; Ishida H; Ueda K; Ideta H; Kamanaka T; Sobajima A; Takizawa T; Tanaka M; Aoki K; Uemura T; Kato H; Haniu H; Saito N
BMC Cancer; 2020 Jan; 20(1):25. PubMed ID: 31914969
[TBL] [Abstract][Full Text] [Related]
14. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.
Watson MJ; Vignali PDA; Mullett SJ; Overacre-Delgoffe AE; Peralta RM; Grebinoski S; Menk AV; Rittenhouse NL; DePeaux K; Whetstone RD; Vignali DAA; Hand TW; Poholek AC; Morrison BM; Rothstein JD; Wendell SG; Delgoffe GM
Nature; 2021 Mar; 591(7851):645-651. PubMed ID: 33589820
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells and innate immune regulation in tumor immunity.
Wang RF
Springer Semin Immunopathol; 2006 Aug; 28(1):17-23. PubMed ID: 16838179
[TBL] [Abstract][Full Text] [Related]
16. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.
van Herk EH; Te Velde AA
J Gastroenterol Hepatol; 2016 Aug; 31(8):1393-404. PubMed ID: 26990130
[TBL] [Abstract][Full Text] [Related]
17. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiles of regulatory T cells in the tumour microenvironment.
Rao D; Verburg F; Renner K; Peeper DS; Lacroix R; Blank CU
Cancer Immunol Immunother; 2021 Sep; 70(9):2417-2427. PubMed ID: 33576875
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
